Chiang Ming-Fu (Alan)'s Form 4/A amendment
AmendedNeonc Technologies Holdings, Inc. (NTHI) · filed Apr 8, 2025
- Accession no.
- 0001213900-25-030063
- Filed
- Apr 8, 2025
- Trade date
- Mar 26, 2025
- Filing delay
- 13 days
- Rule 10b5-1 plan
- Not checked
- Original filed
- Mar 28, 2025
This filing lists 5 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.43M. It was filed 13 days after the trade.
This filing was later replaced by the amendment 0001213900-25-051691 (Jun 5, 2025). Trade tables on this site use the amended version.
This amendment replaces 0001013762-25-004349 (filed Mar 28, 2025).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Chiang Ming-Fu (Alan)CIK 0002055126 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 26, 2025 | Common Stock | AGrant or awardAcquired | +50,000 | $0.00 | $0 | 390,216 | Direct | |
| Mar 26, 2025 | Common Stock | JOtherDisposed | −5,994 | $0.00F3 | $0 | 324,688 | Indirect | |
| Mar 26, 2025 | Common Stock | XIn-the-money exerciseAcquired | +117,188 | $12.00 | +$1,406,256 | 441,876 | Indirect | |
| Mar 26, 2025 | Common Stock | SSaleDisposed | −56,250 | $25.00 | −$1,406,250 | 385,626 | Indirect | |
| Mar 26, 2025 | Common Stock | SSaleDisposed | −1,446 | $19.13 | −$27,661.98 | 384,180 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 26, 2025 | Common Stock | XIn-the-money exerciseDisposed | −117,188 | $0.00 | $0 | 0 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Grant of 50,000 shares of restricted common stock (the "Shares") pursuant to Issuer's 2023 Equity Incentive Plan. The Shares vest 100% seven months after the effective date of Issuer's initial listing.
- F2
Transfer of shares of common stock held by HCWG LLC ("HCWG") pursuant to agreement. The shares reported herein represent only Reporting Person's percentage interest in HCWG LLC. See also footnote 4.
- F3
Not applicable. Number of shares transferred was based on a per share value of $18.
Referenced by the price of 1 transaction in Table I.
- F4
Such shares are held by virtue of beneficial ownership of HCWG. The shares represent only Reporting Person's 37.5% interest in HCWG.
- F5
On 3/26/2025, in conjunction with Issuer's initial listing on Nasdaq, HCWG exercised a warrant to purchase 312,500 shares of Issuer's common stock at $12 per share. HCWG paid the exercise price on a cashless basis, resulting in Issuer's withholding 150,000 of the warrant shares to pay the exercise price and issuing to HCWG the remaining 162,500 shares of common stock. Number of shares reported herein as acquired and disposed of by the Reporting Person represents Reporting Person's indirect interest in HCWG.
- F6
Shares held by Orion Biotech Inc. ("Orion"). Orion is owned in part by Reporting Person, who disclaims beneficial ownership of such shares except to the extent of his pecuniary interest, if any, therein.
- F7
Shares held by NeuCen Biomedical Co. Ltd. ("NeuCen"). NeuCen is owned in part by Reporting Person's spouse. Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest, if any, therein.
- F8
Shares held by certain members of Reporting Person's family. Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest, if any, therein.
- F9
Not applicable.